What’s Going On With Lucid Group Stock?
Shares of Lucid Group Inc (NASDAQ: LCID) are trading higher Friday, lifted by a series of strategic announcements. read more
Shares of Lucid Group Inc (NASDAQ: LCID) are trading higher Friday, lifted by a series of strategic announcements. read more
Accenture plc (NYSE: ACN) posted better-than-expected fourth-quarter 2025 results on Thursday. Latest Ratings for ACN Date Firm Action From To Mar 2022 Goldman Sachs Maintains Neutral Jan 2022 Goldman Sachs Initiates Coverage On Neutral Dec 2021 Barclays Maintains Overweight View More Analyst Ratings for ACN View the Latest Analyst Ratings read more
Baidu (NASDAQ: BIDU) is pushing its Apollo Go robotaxi business into new markets, including Australia, as the service reaches operational profitability in several Chinese cities. read more
PulteGroup (NYSE: PHM) has outperformed the market over the past 10 years by 8.04% on an annualized basis producing an average annual return of 21.15%. Currently, PulteGroup has a market capitalization of $25.69 billion. read more
Accenture (NYSE: ACN) reported fourth-quarter revenue of $17.6 billion, topping expectations, with bookings rising 3% to $21.3 billion. Latest Ratings for ACN Date Firm Action From To Mar 2022 Goldman Sachs Maintains Neutral Jan 2022 Goldman Sachs Initiates Coverage On Neutral Dec 2021 Barclays Maintains Overweight View More Analyst Ratings for ACN View the Latest…
BlackBerry Limited (NYSE: BB) posted upbeat second-quarter results on Thursday. Latest Ratings for BB Date Firm Action From To Aug 2021 Canaccord Genuity Upgrades Sell Hold Jun 2021 TD Securities Downgrades Hold Reduce Jun 2021 CIBC Downgrades Neutral Underperform View More Analyst Ratings for BB View the Latest Analyst Ratings read more
Gold is up 43% this year, but Wall Street still owns very little. Here’s why analysts think prices could keep climbing. read more
Raymond James Financial, Inc. (NYSE: RJF) shares are trading relatively flat on Friday in the premarket session. read more
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday’s session after the FDA approved PALSONIFY. read more